Events & Presentations
Upcoming Events
| Date | Event Details | Remind Me |
|---|---|---|
|
Jul 28, 2020 12:00 PM EDT
|
ARO-ENaC KOL Webinar
|
|
|
Aug 5, 2020 4:30 PM EDT
|
Arrowhead Pharmaceuticals 2020 Third Quarter Results
|
Archived Events
| Date | Event Details |
|---|---|
|
Feb 27 - Mar 1, 2018 12:00 AM EST
|
AsiaTIDES: Oligonucleotide and Peptide Therapeutics
Kyoto, Japan
|
|
Feb 22, 2018 3:10 PM UTC
|
SMI RNA Therapeutics Conference
London
|
|
Feb 9, 2018 4:30 PM EST
|
Arrowhead Fiscal 2018 First Quarter Results
|
|
Jan 8 - Jan 10, 2018 12:00 AM EST
|
JP Morgan Healthcare Conference Week
Corporate Presentation 1.9 MB
|
|
Dec 12, 2017 4:30 PM EST
|
Arrowhead Pharmaceuticals 2017 Fiscal Year End Results
|
|
Dec 5, 2017 6:10 PM HST
|
HEP DART 2017
Kona, Hawaii
|
|
Nov 28, 2017 9:30 AM EST
|
29th Annual Piper Jaffray Healthcare Conference
|
|
Nov 13 - Nov 15, 2017 12:00 AM EST
|
BIT's 8th World Gene Convention-2017
Macau, China
|
|
Oct 23, 2017
|
The Liver Meeting® 2017, the Annual Meeting of the American Association for the Study of Liver Disease
View Presentation 890.9 KB
Washington, DC
Subcutaneous delivery of a RNA interference (RNAi) therapeutic candidate for alpha-1 antitrypsin deficiency (AATD)-related liver disease produces deep and prolonged knockdown of plasma AAT
· Authors: Christine I. Wooddell, et al. |
|
Oct 10, 2017 10:45 AM EDT
|
Chardan Gene Therapy Conference
|